Home › Funds › CAPITOLIS LIQUID GLOBAL MARKETS LLC › ELV

CAPITOLIS LIQUID GLOBAL MARKETS LLC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

CAPITOLIS LIQUID GLOBAL MARKETS LLC reported holding 387,985 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$150.9M, representing 0.67% of its reported portfolio and ranking #30 among its reported holdings. CAPITOLIS LIQUID GLOBAL MARKETS LLC has disclosed ELV holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)387.99K sh
Reported value held$150.86M
Portfolio Weight0.67%
First reportedQ4 2024
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How CAPITOLIS LIQUID GLOBAL MARKETS LLC's ELV position evolved

CAPITOLIS LIQUID GLOBAL MARKETS LLC first disclosed a stake in ELV in Q4 2024 at 45,000 shares (US$16.6M). The position peaked in Q2 2026 at 614,190 shares, worth US$237.5M. Across 8 filings, CAPITOLIS LIQUID GLOBAL MARKETS LLC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 387,985 shares valued at US$150.9M — a reduction of -226,205 shares quarter over quarter.. Notable position changes include a 97% increase in Q4 2025 (shares fell 16% over the following quarter), a 844% increase in Q2 2026 (shares were roughly flat over the following quarter), a 37% trim in Q3 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 45.00K $16.60M New
Q1 2025 45.00K $19.57M Hold
Q2 2025 38.00K $14.78M Reduce
Q3 2025 38.00K $12.28M Hold
Q4 2025 75.00K $26.29M Add
Q1 2026 65.04K $19.04M Reduce
Q2 2026 614.19K $237.53M Add
Q3 2026 387.99K $150.86M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 24 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has CAPITOLIS LIQUID GLOBAL MARKETS LLC held ELV?

CAPITOLIS LIQUID GLOBAL MARKETS LLC has disclosed ELV holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is CAPITOLIS LIQUID GLOBAL MARKETS LLC's current position in ELV?

As of Q3 2026, CAPITOLIS LIQUID GLOBAL MARKETS LLC holds 387.99K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $150.86M, representing 0.67% of its reported portfolio and ranking #30.

Has CAPITOLIS LIQUID GLOBAL MARKETS LLC been buying or selling ELV?

In the latest 13F filing (Q3 2026), CAPITOLIS LIQUID GLOBAL MARKETS LLC reduced its position in ELV. The position peaked in Q2 2026 at 614.19K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.